24.12.2012 Views

Evidence base and patients' perspective - World Journal of ...

Evidence base and patients' perspective - World Journal of ...

Evidence base and patients' perspective - World Journal of ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

A<br />

Macroscopir damage scores (AU)<br />

7.5<br />

5.0<br />

2.5<br />

0.0<br />

Sham-colitis TNBS<br />

Figure 1 Effect <strong>of</strong> a 6 wk juvenile ingestion <strong>of</strong> ferrous (150 mg/kg per day po) vs ferric (150 mg/kg per day po) iron on the inflammatory response at adulthood<br />

to a trinitrobenzene sulfonic acid-induced colitis in mice. A: Macroscopic damage scores in non-inflamed (sham-colitis) <strong>and</strong> inflamed (trinitrobenzene sulfonic<br />

acid, TNBS) mice; B: Colonic myeloperoxidase (MPO) activity in non-inflamed (sham-colitis) <strong>and</strong> inflamed (TNBS) mice. Data are expressed as mean ± SE (n = 8 per<br />

group). a P < 0.05 vs TNBS-treated group, b P < 0.01 vs Sham-colitis.<br />

Effects <strong>of</strong> ferric iron on TNBS colitis<br />

Repeated daily ingestion <strong>of</strong> ferrous iron (150 mg/kg<br />

per day po - 6 wk) by juvenile mice did not prevent the<br />

induction <strong>of</strong> a TNBS-induced moderate colitis. In fact,<br />

juvenile ferrous iron daily exposure failed to limit macroscopic<br />

lesions (Figure 1A) in TNBS treated mice. In contrast,<br />

juvenile ferric iron prevented these lesions (Figure<br />

1A) in inflamed mice. Furthermore, while TNBS enema<br />

resulted in an increased MPO activity in controls (2.47<br />

± 0.22 MPO U/mg protein vs 0.91 ± 0.09 MPO U/mg<br />

protein), we did not observe any significant reduction <strong>of</strong><br />

MPO activity in mice exposed to a repeated ingestion <strong>of</strong><br />

ferrous iron (1.71 ± 0.27 MPO U/mg protein vs 2.47 ±<br />

0.22 MPO U/mg protein in the TNBS group) (Figure<br />

1B). In contrast, the daily exposure <strong>of</strong> juvenile mice to<br />

the same dose <strong>of</strong> ferric iron (150 mg/kg per day po - 6<br />

wk) was able to limit the inflammatory response since<br />

MPO activity was significantly lower (P < 0.05) (1.64 ±<br />

0.14 MPO U/mg protein vs 2.47 ± 0.22 MPO U/mg<br />

protein in the TNBS group) (Figure 1B). Furthermore,<br />

we observed that before inducing TNBS colitis (5 wk <strong>of</strong><br />

treatment), mice treated with ferrous iron put on significantly<br />

(P < 0.05) less weight than mice treated with ferric<br />

iron <strong>and</strong> controls (124.6% ± 1.12% <strong>and</strong> 136.6% ± 1.33<br />

WJG|www.wjgnet.com<br />

b<br />

a<br />

7.5<br />

5.0<br />

2.5<br />

0.0<br />

Sham-colitis TNBS<br />

A B Vehicle<br />

Macroscopir damage scores (AU)<br />

7.5<br />

5.0<br />

2.5<br />

0.0<br />

Sham-colitis TNBS<br />

d<br />

b<br />

b<br />

B<br />

MPO activity (U/mg protein)<br />

MPO activity (U/mg protein)<br />

3.0<br />

2.5<br />

2.0<br />

1.5<br />

1.0<br />

0.5<br />

0.0<br />

Ettreiki C et al . Iron prevents colitis <strong>and</strong> dysbiosis<br />

b<br />

Sham-colitis TNBS<br />

% vs 143.7% ± 2.29 % in control, respectively).<br />

a<br />

Vehicle<br />

Ferric iron (150 mg/kg per day po)<br />

Ferrous iron (150 mg/kg per day po)<br />

Ferric iron (75 mg/kg per day po)<br />

Ferric iron (150 mg/kg per day po)<br />

Figure 2 Effect <strong>of</strong> a 6 wk juvenile ferric iron administration (75 <strong>and</strong> 150 mg/kg per day po) on the inflammatory response at adulthood to a trinitrobenzene<br />

sulfonic acid-induced colitis in mice. A: Macroscopic damage scores in non-inflamed (sham-colitis) <strong>and</strong> inflamed trinitrobenzene sulfonic acid (TNBS) mice; B: Colonic<br />

myeloperoxidase (MPO) activity in non-inflamed (sham-colitis) <strong>and</strong> inflamed (TNBS) mice. Data are expressed as mean ± SE (n = 8 per group). a P < 0.05, b P < 0.01<br />

vs TNBS-treated group, d P < 0.01 vs Sham-colitis.<br />

d<br />

Ferric iron juvenile supplementation <strong>and</strong> dysbiosis<br />

We also aimed at determining the dose-response effect <strong>of</strong><br />

ferric iron supplementation on the same model <strong>of</strong> colitis<br />

in mice.<br />

In control animals, the repeated administration <strong>of</strong><br />

both 75 <strong>and</strong> 150 mg/kg per day po (6 wk) <strong>of</strong> ferric iron<br />

did not result in any alteration <strong>of</strong> growth, nor did it result<br />

in colonic inflammation or an alteration <strong>of</strong> the micr<strong>of</strong>lora<br />

pr<strong>of</strong>ile. In fact, weight gain under iron treatment<br />

remained similar whichever species considered (142.7%<br />

± 2.66% for 75 mg/kg per day <strong>and</strong> 136.6% ± 1.33 % for<br />

150 mg/kg per day vs 143.7% ± 2.29 % in controls). Similarly,<br />

no macroscopic alterations <strong>of</strong> the gut mucosa have<br />

been observed on mice following either the low or the<br />

high chronic ferric supplementation (Figure 2A). Those<br />

results were correlated to low levels <strong>of</strong> MPO activity in<br />

the colonic mucosa following exposure to both doses<br />

<strong>of</strong> ferric iron (1.65 ± 0.21 MPO U/mg protein <strong>and</strong> 1.58<br />

± 0.11 MPO U/mg protein for respectively 75 <strong>and</strong> 150<br />

mg/kg per day ferric iron po vs 0.91 ± 0.09 MPO U/mg<br />

protein in controls) (Figure 2B). Daily consumption <strong>of</strong><br />

ferric iron by juvenile rodents did not modify the bacte-<br />

2623 June 7, 2012|Volume 18|Issue 21|<br />

a<br />

a

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!